← Open Payments lookup

STEPHEN MCLEOD-BRYANT: Open Payments

NPI 1669580510 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$604 in 22 payments from 8 companies in 2025. Trend: 2023 $368 · 2024 $883 · 2025 $604

Food & beverage: $604
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$141
ACADIA Pharmaceuticals Inc1$113
Janssen Pharmaceuticals, Inc3$88
Teva Pharmaceuticals USA, Inc.4$76
Otsuka America Pharmaceutical, Inc.3$69
ABBVIE INC.2$49
Vanda Pharmaceuticals Inc.2$46
Alkermes, Inc.1$22

Products named: INGREZZA, NUPLAZID, INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, FANAPT.

Industry payments across FL — which companies pay providers there.